The dynamics of HER2-low expression during breast cancer progression

被引：0
|
作者：
Sarah Anderson
Brooke Baxter Bartow
Gene P. Siegal
Xiao Huang
Shi Wei
机构：
[1] The University of Alabama at Birmingham,Department of Pathology
[2] The University of Kansas Medical Center,Department of Pathology and Laboratory Medicine
来源：
Breast Cancer Research and Treatment | 2023年 / 201卷
关键词：
Breast cancer; HER2-low; Immunohistochemistry; In situ hybridization; Amplification; Overexpression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [31] Frequency of HER2-Low in breast cancer biopsies in Chile
    Vidal, Martin
    Rivera, Alvaro
    Schuler, Constanza
    Garnham, Nicolas
    Alcalde, Elisa
    Renner, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] TRASTUZUMAB DERUXTECAN IS EFFECTIVE IN HER2-LOW BREAST CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [33] HER2-low breast cancer: insights on pathological testing
    Liu, Yueping
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [34] HER2-Low Breast Cancer: Pathological and Clinical Landscape
    Tarantino, Paolo
    Hamilton, Erika
    Tolaney, Sara M.
    Cortes, Javier
    Morganti, Stefania
    Ferraro, Emanuela
    Marra, Antonio
    Viale, Giulia
    Trapani, Dario
    Cardoso, Fatima
    Penault-Llorca, Frederique
    Viale, Giuseppe
    Andre, Fabrice
    Curigliano, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1951 - +
  • [35] HER2-low breast cancer: A new clinical entity
    Rashid, Yasmin Abdul
    Khan, Samra
    Khan, Shagufta
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (01) : 149 - 150
  • [36] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [37] Genomic and transcriptomic landscape of HER2-low breast cancer
    Bansal, Rani
    Adeyelu, Tolulope
    Elliott, Andrew
    Walker, Phillip
    Bustos, Matias A.
    Rodriguez, Estelamari
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret E.
    Hsu, Emily
    Lathrop, Kate
    Kaklamani, Virginia
    Oberley, Matthew
    Sledge, George
    Sammons, Sarah L.
    Graff, Stephanie L.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (02) : 323 - 330
  • [38] Insights Into the Emerging Entity of HER2-Low Breast Cancer
    El Haddad, Georges
    Diab, Ernest
    Hajjar, Michel
    Aoun, Maroun
    Mallat, Farid
    Zalaquett, Ziad
    Kourie, Hampig-Raphael
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2024, 2024
  • [39] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [40] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Horisawa, Nanae
    Adachi, Yayoi
    Takatsuka, Daiki
    Nozawa, Kazuki
    Endo, Yuka
    Ozaki, Yuri
    Sugino, Kayoko
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (02) : 234 - 241
12345